CDD-1845

CAT: 0804-HY-155144-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-155144-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDD-1845 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 3 nM. CDD-1845 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1].
CAS Number
[2894104-50-6]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cdd-1845.html
Purity
99.60
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(NC)CCCN1C(C2=C(C=CC=C3)C3=CN=C2)=NC4=C1C(C(N[C@@H](C)C5=CC=C(C=CC=C6)C6=C5)=O)=CC=C4
Molecular Formula
C34H31N5O2
Molecular Weight
541.64
References & Citations
[1]Ravikumar Jimmidi, et al. DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors. Commun Chem. 2023 Aug 4;6 (1) :164.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-162565-01CDD-2807
HY-177143CDD-1498
HY-171248CDD-1115
HY-177140CDD-1147
HY-176885CDD-2211
HY-176884CDD-2110
HY-171249CDD-1431
HY-162779-01CDD-3290
HY-155142CDD-1819
HY-179510CDD-1274

Alternative Products

CatalogName
MBS5821008CDD-1845
B6880-50MRS 1845
574800MRS-1845
MF-0122137-01CDD-3290
MF-0121835-01CDD-1653
MF-0157172-01CDD-1733
MF-0117601-01CDD-2807
MBS5821006CDD-1819
MF-0113563-01CDD-1281
MF-0114630-01CDD-2789

Popular Products